Dr. Patrick Meeus
About Dr. Patrick Meeus
Dr. Patrick Meeus serves as the Chief Scientific Officer at Dechra Pharmaceuticals PLC, bringing extensive experience in animal health and welfare from his previous roles at Pfizer, Elanco, and Zoetis Inc. He holds a PhD in Infectious Diseases from the University of Florida and has a strong background in organizational optimization and international collaboration.
Current Role at Dechra Pharmaceuticals
Dr. Patrick Meeus serves as the Chief Scientific Officer at Dechra Pharmaceuticals PLC. He has held this position since 2022, contributing to the company's strategic direction in scientific research and development. His role involves overseeing various initiatives aimed at enhancing animal health and welfare through innovative solutions.
Previous Experience at Elanco
Prior to his current role, Dr. Meeus worked at Elanco in multiple capacities. He was the Senior Research Fellow and R&D Site Leader from 2020, following his tenure as Executive Director of Product Development and R&D site leader in Basel Area, Switzerland, from 2019 to 2020. His work at Elanco focused on advancing product development in the animal health sector.
Experience at Pfizer
Dr. Meeus has extensive experience at Pfizer, where he held several positions from 2004 to 2012. He served as Manager of Global Clinical Development, Director of Global Therapeutics Research in Parasitology, and Associate Director of Global Clinical Development. His roles involved leading teams and projects aimed at developing therapeutic solutions for animal health.
Educational Background
Dr. Meeus earned his BVSc and DVM degrees from Universiteit Gent. He furthered his education at the University of Florida, where he achieved a PhD in Infectious Diseases. Additionally, he studied at the Australian Institute of Company Directors, focusing on Company and Legal Entity Management, and became a Diplomate of the American College of Veterinary Microbiologists in Parasitology.
Expertise in Animal Health and Business Development
Dr. Meeus possesses global expertise in external collaborations and business development, which has contributed to sustainable improvements in animal health and welfare. He has a strong background in organizational optimization, enhancing the efficiency of research and development processes, and has successfully navigated diverse organizational structures across geographical and cultural barriers.